Related Experiment Video
Updated: Mar 8, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
Bacterial-Derived Polymer Poly-y-Glutamic Acid (y-PGA)-Based Micro/Nanoparticles as a Delivery System for
Ibrahim R Khalil1,2, Alan T H Burns3, Iza Radecka4
1Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UK. Grazyna.Adamus@cmpw-pan.edu.pl.
Abstract:
In the past decade, poly-γ-glutamic acid (γ-PGA)-based micro/nanoparticles have garnered remarkable attention as antimicrobial agents and for drug delivery, owing to their controlled and sustained-release properties, low toxicity, as well as biocompatibility with tissue and cells. γ-PGA is a naturally occurring biopolymer produced by several gram-positive bacteria that, due to its biodegradable, non-toxic and non-immunogenic properties, has been used successfully in the medical, food and wastewater industries. Moreover, its carboxylic group on the side chains can offer an attachment point to conjugate antimicrobial and various therapeutic agents, or to chemically modify the solubility of the biopolymer. The unique characteristics of γ-PGA have a promising future for medical and pharmaceutical applications. In the present review, the structure, properties and micro/nanoparticle preparation methods of γ-PGA and its derivatives are covered. Also, we have highlighted the impact of micro/nanoencapsulation or immobilisation of antimicrobial agents and various disease-related drugs on biodegradable γ-PGA micro/nanoparticles.
Insights
Poly-γ-glutamic acid (γ-PGA) micro/nanoparticles show promise for drug delivery and as antimicrobial agents due to their biocompatibility and controlled release. This review covers γ-PGA
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Nanotechnology
Background:
- Poly-γ-glutamic acid (γ-PGA) is a biodegradable, non-toxic, and non-immunogenic biopolymer produced by bacteria.
- Its unique properties and carboxylic acid groups allow for conjugation with therapeutic agents.
- γ-PGA has found applications in medical, food, and wastewater industries.
Purpose of the Study:
- To review the structure, properties, and preparation methods of γ-PGA and its derivatives.
- To highlight the impact of encapsulating antimicrobial and therapeutic agents within γ-PGA micro/nanoparticles.
- To explore the potential of γ-PGA-based systems in drug delivery and antimicrobial applications.
Main Methods:
- Literature review focusing on γ-PGA structure, properties, and synthesis.
- Analysis of studies involving the micro/nanoencapsulation of active agents onto γ-PGA.
- Examination of the controlled and sustained-release characteristics of γ-PGA formulations.
Main Results:
- γ-PGA micro/nanoparticles offer controlled and sustained release of encapsulated agents.
- These particles exhibit low toxicity and excellent biocompatibility with biological systems.
- The carboxylic groups on γ-PGA facilitate the attachment and conjugation of various drugs and antimicrobials.
Conclusions:
- γ-PGA-based micro/nanoparticles are highly promising for advanced drug delivery systems.
- Their inherent biocompatibility and biodegradability make them suitable for biomedical applications.
- Further research into γ-PGA derivatives can unlock new therapeutic possibilities.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Microorganisms in Medicine and Therapeutics

